INDIA BUSINESS WORLD - February 1^st - February 15^th - 2008

ZYDUS CADILA ENTERS INTO PACT WITH SWEDISH FIRM KARO BIO

Pharma firm Cadila Healthcare has said that it has entered into a strategic collaboration with Sweden-based Karo Bio to discover and develop drug for treatment of inflammatory diseases. Cadila has signed a three-year research agreement in the area of drug discovery for selective glucocorticoid receptor (GR) modulators for the treatment of rheumatoid arthritis, psoriasis and asthma, the company informed the BSE. "One of the key research areas of focus at our Zydus Research Centre is to develop novel GR modulators that are devoid of side effects," Zydus Cadila CMD Pankaj R Patel said.